Archives duchenne-muscular-dystrophy

by in
Entry Author Date Location
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
West Coast Biotech Roundup: BioMarin, Tocagen, Medivation, Twelve 08/27/15 San Diego
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More 07/06/15 Seattle
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
BioMarin, Sarepta Update Positions In Race To Produce DMD Drug 06/29/15 San Francisco
Retooled Catabasis Cuts Price, Upsizes to Grab $60M in IPO 06/25/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank 10/27/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Sarepta Abruptly Fires CSO and RNA Vet Krieg 07/24/14 Boston
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
EU Reverses Course on PTC Drug, Shares Boom 05/23/14 New York
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Sarepta to Submit Application for Duchenne Drug, Shares Boom 04/21/14 Boston
Page 1 of 3 next page »